Profil
Chris Cargill is currently the President, CEO & Representative Director at Nxera Pharma Co., Ltd. since 2022.
He is also currently a Director at Nxera Pharma UK Ltd. since 2019.
Previously, he worked as a Director at Sosei R&D Ltd. Mr. Cargill completed his undergraduate degree at Monash University.
Aktive Positionen von Chris Cargill
| Unternehmen | Position | Beginn |
|---|---|---|
| NXERA PHARMA CO., LTD. | Vorstandsvorsitzender | 24.03.2022 |
Nxera Pharma UK Ltd.
Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors | Direktor/Vorstandsmitglied | 01.01.2019 |
Ehemalige bekannte Positionen von Chris Cargill
| Unternehmen | Position | Ende |
|---|---|---|
Sosei R&D Ltd.
Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | - |
Ausbildung von Chris Cargill
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Monash University
Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sosei R&D Ltd.
Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Nxera Pharma Co., Ltd.
Nxera Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops bio pharmaceutical products | Health Technology |
Nxera Pharma UK Ltd.
Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors | Health Technology |
















